INS and type 2 diabetes mellitus: A total of 18 (7%) subjects had diet-controlled T2D, 128 (52%) were taking a single oral glucose-lowering agent, 64 (26%) were taking two or agents, 17 (7%) were taking three or more oral agents, and 20 (8%) were insulin-treated.